Corona Remedies Ltd vs Parnax Lab Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Corona Remedies Ltd is ₹ 1728 as of 12 Jun 15:30 . The P/E Ratio of Corona Remedies Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Parnax Lab Ltd changed from 15.7 on March 2022 to 10.7 on March 2025 . This represents a CAGR of -9.14% over 4 years The Market Cap of Corona Remedies Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Parnax Lab Ltd changed from ₹ 16.58 crore on March 2021 to ₹ 122.9 crore on March 2025 . This represents a CAGR of 49.28% over 5 years The revenue of Corona Remedies Ltd for the Mar '26 is ₹ 357.48 crore as compare to the Dec '25 revenue of ₹ 344.68 crore. This represent the growth of 3.71% The revenue of Parnax Lab Ltd for the Mar '26 is ₹ 71.62 crore as compare to the Dec '25 revenue of ₹ 63.91 crore. This represent the growth of 12.06% The ebitda of Corona Remedies Ltd for the Mar '26 is ₹ 66.41 crore as compare to the Dec '25 ebitda of ₹ 66.32 crore. This represent the growth of 0.14% The ebitda of Parnax Lab Ltd for the Mar '26 is ₹ 6.65 crore as compare to the Dec '25 ebitda of ₹ 6.68 crore. This represent the decline of -0.45% The net profit of Corona Remedies Ltd changed from ₹ 29.95 crore to ₹ 45.33 crore over 8 quarters. This represents a CAGR of 23.03% The net profit of Parnax Lab Ltd changed from ₹ 3.99 crore to ₹ 2.18 crore over 8 quarters. This represents a CAGR of -26.08% The Dividend Payout of Corona Remedies Ltd changed from 20 % on March 2023 to 30 % on March 2025 . This represents a CAGR of 14.47% over 3 yearsThe Dividend Payout of Parnax Lab Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Corona Remedies Ltd

Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli.
Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'.
A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024. The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat).
The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005.

About Parnax Lab Ltd

Parnax Lab Limited, formerly Known as Krishna Deep Trade & Investment Limited was incorporated in August, 1982.
The Company changed the name from Krishna Deep Trade & Investment Ltd to Parnax Lab Limited with effect from July 19, 2012.
The Company engages in the business activities of manufacturing and export of Pharmaceutical Formulations.
Initially, it was engaged in investment and financing activities. Naxpar Pharma Private Limited is Subsidiary Company of the Holding Company.
With over two decades of rich experience behind it, the Naxpar Group is at the helm of innovation in the manufacturing of Pharmaceuticals, Cosmetics, Herbal/Ayurvedic formulations & Nutraceuticals (FSSAI) products.

FAQs for the comparison of Corona Remedies Ltd and Parnax Lab Ltd

Which company has a larger market capitalization, Corona Remedies Ltd or Parnax Lab Ltd?

Market cap of Corona Remedies Ltd is 10,570 Cr while Market cap of Parnax Lab Ltd is 149 Cr

What are the key factors driving the stock performance of Corona Remedies Ltd and Parnax Lab Ltd?

The stock performance of Corona Remedies Ltd and Parnax Lab Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Corona Remedies Ltd and Parnax Lab Ltd?

As of June 15, 2026, the Corona Remedies Ltd stock price is INR ₹1728.4. On the other hand, Parnax Lab Ltd stock price is INR ₹130.1.

How do dividend payouts of Corona Remedies Ltd and Parnax Lab Ltd compare?

To compare the dividend payouts of Corona Remedies Ltd and Parnax Lab Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.